FDA — authorised 16 October 2003
- Marketing authorisation holder: FOREST LABS LLC
- Status: approved
🇺🇸 Namenda in United States
FDA authorised Namenda on 16 October 2003
Marketing authorisations
FDA — authorised 16 October 2003
- Application: NDA021487
- Marketing authorisation holder: ABBVIE
- Local brand name: NAMENDA
- Indication: TABLET — ORAL
- Status: approved
Namenda in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Namenda approved in United States?
Yes. FDA authorised it on 16 October 2003; FDA authorised it on 16 October 2003.
Who is the marketing authorisation holder for Namenda in United States?
FOREST LABS LLC holds the US marketing authorisation.